Sean Lavin
Stock Analyst at BTIG
(3.10)
# 1,232
Out of 4,711 analysts
46
Total ratings
81.82%
Success rate
38.68%
Average return
Main Sectors:
Stocks Rated by Sean Lavin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TCMD Tactile Systems Technology | Downgrades: Neutral | n/a | $17.00 | - | 4 | Nov 5, 2024 | |
| HOLX Hologic | Downgrades: Neutral | n/a | $71.65 | - | 5 | Jul 18, 2022 | |
| PODD Insulet | Upgrades: Buy | $320 | $266.57 | +20.04% | 5 | Feb 3, 2022 | |
| MDT Medtronic | Downgrades: Neutral | n/a | $81.03 | - | 1 | Jan 10, 2022 | |
| ATRC AtriCure | Maintains: Buy | $42 → $48 | $30.72 | +56.25% | 3 | Feb 19, 2020 | |
| MASI Masimo | Downgrades: Neutral | n/a | $169.52 | - | 4 | Apr 16, 2019 | |
| HSDT Helius Medical Technologies | Downgrades: Neutral | n/a | $0.91 | - | 4 | Apr 16, 2019 | |
| IRTC iRhythm Technologies | Upgrades: Buy | $80 | $90.39 | -11.49% | 3 | Apr 3, 2019 | |
| NEO NeoGenomics | Upgrades: Outperform | n/a | $16.41 | - | 4 | Apr 16, 2018 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $59.40 | - | 3 | Apr 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $114.23 | - | 1 | Jan 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.16 | - | 1 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $88.95 | - | 1 | Nov 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $80.04 | - | 3 | May 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $74.81 | - | 4 | Feb 2, 2017 |
Tactile Systems Technology
Nov 5, 2024
Downgrades: Neutral
Price Target: n/a
Current: $17.00
Upside: -
Hologic
Jul 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $71.65
Upside: -
Insulet
Feb 3, 2022
Upgrades: Buy
Price Target: $320
Current: $266.57
Upside: +20.04%
Medtronic
Jan 10, 2022
Downgrades: Neutral
Price Target: n/a
Current: $81.03
Upside: -
AtriCure
Feb 19, 2020
Maintains: Buy
Price Target: $42 → $48
Current: $30.72
Upside: +56.25%
Masimo
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $169.52
Upside: -
Helius Medical Technologies
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $0.91
Upside: -
iRhythm Technologies
Apr 3, 2019
Upgrades: Buy
Price Target: $80
Current: $90.39
Upside: -11.49%
NeoGenomics
Apr 16, 2018
Upgrades: Outperform
Price Target: n/a
Current: $16.41
Upside: -
Exact Sciences
Apr 3, 2018
Upgrades: Buy
Price Target: n/a
Current: $59.40
Upside: -
Jan 22, 2018
Downgrades: Neutral
Price Target: n/a
Current: $114.23
Upside: -
Dec 13, 2017
Downgrades: Neutral
Price Target: n/a
Current: $1.16
Upside: -
Nov 30, 2017
Upgrades: Buy
Price Target: n/a
Current: $88.95
Upside: -
May 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $80.04
Upside: -
Feb 2, 2017
Downgrades: Neutral
Price Target: n/a
Current: $74.81
Upside: -